Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
25.12
+0.68 (2.78%)
At close: Dec 24, 2025, 1:00 PM EST
25.33
+0.21 (0.84%)
After-hours: Dec 24, 2025, 4:16 PM EST
Astrana Health Stock Forecast
Stock Price Forecast
The 9 analysts that cover Astrana Health stock have a consensus rating of "Strong Buy" and an average price target of $41.33, which forecasts a 64.53% increase in the stock price over the next year. The lowest target is $26 and the highest is $56.
Price Target: $41.33 (+64.53%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +11.46% | Dec 12, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $44 → $37 | Strong Buy | Maintains | $44 → $37 | +47.29% | Nov 25, 2025 |
| Barclays | Barclays | Hold Maintains $36 → $26 | Hold | Maintains | $36 → $26 | +3.50% | Nov 24, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +39.33% | Nov 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +79.14% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
3.22B
from 2.03B
Increased by 58.46%
Revenue Next Year
4.05B
from 3.22B
Increased by 25.59%
EPS This Year
0.50
from 0.90
Decreased by -44.05%
EPS Next Year
1.28
from 0.50
Increased by 153.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.3B | 4.4B | ||||
| Avg | 3.2B | 4.0B | ||||
| Low | 3.1B | 3.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 64.4% | 36.7% | ||||
| Avg | 58.5% | 25.6% | ||||
| Low | 51.0% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.76 | 2.08 | |
| Avg | 0.50 | 1.28 | |
| Low | 0.32 | 0.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -16.0% | 312.9% | |
| Avg | -44.1% | 153.2% | |
| Low | -64.1% | -94.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.